Kristel Tjandra is a science journalism intern at Drug Discovery News. She earned a PhD in chemistry from the University of New South Wales, Australia. Kristel is currently a postdoctoral scholar at Stanford University where she develops rapid diagnostics for multidrug-resistant bacteria. Her research focuses on therapeutics and diagnostics for cancer and infectious diseases. When not writing, she enjoys spending time outdoors playing tennis, cycling, and swimming.
A new understanding of one enzyme’s role in assembling a key macromolecule in the bacterial cell wall takes a step toward overcoming antibiotic resistance.
Scientists found that the Kisspeptin hormone activates enzymes that stop lipid formation in the mouse liver, suggesting that it has potential as a drug target for treating non-alcoholic fatty liver disease.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.